Stocks
Agios Pharmaceuticals (AGIO) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 10.3% | 7.34% | 34.3% | 3.72% | 2.90% | ||||
| Changes by years, y/y, % | +3pp | -3pp | -7pp | -31pp | -12.8% | ||||
Agios Pharmaceuticals. CAPEX/Revenue, %
Agios Pharmaceuticals. CAPEX/Revenue, changes, pp
Agios Pharmaceuticals (AGIO) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 241.5% | 3.29% | 1.72% | 1.83% | 4.67% | 2.90% | ||
| Changes by years, y/y, % | +240pp | +1pp | -5pp | +2pp | -237pp | |||
| Changes by quarters, q/q, % | +241pp | -238pp | -2pp | +0pp | +3pp | |||
